mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.003 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.003 |